While Jasper Therapeutics Inc has underperformed by -0.73%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, JSPR fell by -68.33%, with highs and lows ranging from $26.05 to $3.13, whereas the simple moving average fell by -40.89% in the last 200 days.
On February 13, 2025, UBS started tracking Jasper Therapeutics Inc (NASDAQ: JSPR) recommending Buy. A report published by BMO Capital Markets on December 06, 2024, Initiated its previous ‘Outperform’ rating for JSPR. JMP Securities also rated JSPR shares as ‘Mkt Outperform’, setting a target price of $70 on the company’s shares in an initiating report dated September 09, 2024. BTIG Research Initiated an Buy rating on July 08, 2024, and assigned a price target of $90. Stifel initiated its ‘Buy’ rating for JSPR, as published in its report on June 27, 2024. H.C. Wainwright’s report from May 06, 2024 suggests a price prediction of $65 for JSPR shares, giving the stock a ‘Buy’ rating. Evercore ISI also rated the stock as ‘Outperform’.
Analysis of Jasper Therapeutics Inc (JSPR)
To gain a thorough understanding of Jasper Therapeutics Inc’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. The goal here is to ensure that your current return on equity of -101.34% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 4.31, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
It is also very valuable to look at average volume as an indicator of volatility for a stock, and JSPR is recording an average volume of 250.50K. On a monthly basis, the volatility of the stock is set at 8.72%, whereas on a weekly basis, it is put at 11.43%, with a gain of 18.98% over the past seven days. Furthermore, long-term investors anticipate a median target price of $47.88, showing growth from the present price of $6.77, which can serve as yet another indication of whether JSPR is worth investing in or should be passed over.
How Do You Analyze Jasper Therapeutics Inc Shares?
The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 16.21%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 73.92% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
